Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06603168 · ClinicalTrials.gov registry record · NA
Autonomic Recalibration
A NA study, sponsored by Edward Via Virginia College of Osteopathic Medicine.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT06603168 is a NA study that has completed, run by Edward Via Virginia College of Osteopathic Medicine. The registered enrollment target is 20 participants.
The verdict
NCT06603168, a NA study, has completed, sponsored by Edward Via Virginia College of Osteopathic Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn if Autonomic Recalibration works to reduce sympathetic dominance to alleviate dysfunctional myofascial pain. The main questions it aims to answer are: How is the Autonomic Nervous System (ANS) affected during Autonomic Recalibration Treatment (ART)? How are myofascial tissue properties impacted from ART? Participants will: Have 2 treatments of ART on consecutive days. Wear sensors to track HRV (heart rate variability) and GSR to verify autonomic recalibration. Measure changes in range of motion by wearing a Rokoko motion capture suit. Measure changes in muscle stiffness through shear wave elastography.
Interventions
- OTHER Autonomic Recalibration Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2023-04-27 |
| Est. Completion | 2024-02-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06603168
The ClinicalTrials.gov registry entry for NCT06603168 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Edward Via Virginia College of Osteopathic Medicine, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Autonomic Recalibration Treatment is the first listed.
NCT06603168 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06603168 about?
NCT06603168 is a clinical study titled "Autonomic Recalibration". The goal of this clinical trial is to learn if Autonomic Recalibration works to reduce sympathetic dominance to alleviate dysfunctional myofascial pain. The main questions it aims to answer are: How is the Autonomic Nervous System (ANS) affected during Autonomic Recalibration Treatment (ART)? How a...
What is the current status of trial NCT06603168?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2023-04-27. Estimated completion is 2024-02-27.
What interventions are being tested in trial NCT06603168?
The interventions under investigation include: Autonomic Recalibration Treatment (OTHER).
Who is sponsoring clinical trial NCT06603168?
This trial is sponsored by Edward Via Virginia College of Osteopathic Medicine, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.